nodes	percent_of_prediction	percent_of_DWPC	metapath
Loperamide—CALM1—Signaling by FGFR in disease—KRAS—gallbladder cancer	0.00111	0.00111	CbGpPWpGaD
Loperamide—CALM2—Signaling by EGFR—KRAS—gallbladder cancer	0.0011	0.0011	CbGpPWpGaD
Loperamide—CALM1—Signaling by EGFR—KRAS—gallbladder cancer	0.0011	0.0011	CbGpPWpGaD
Loperamide—CALM1—Signaling by EGFR in Cancer—KRAS—gallbladder cancer	0.00109	0.00109	CbGpPWpGaD
Loperamide—CALM2—Signaling by EGFR in Cancer—KRAS—gallbladder cancer	0.00109	0.00109	CbGpPWpGaD
Loperamide—CALM2—B Cell Activation—EGFR—gallbladder cancer	0.00109	0.00109	CbGpPWpGaD
Loperamide—CALM1—B Cell Activation—EGFR—gallbladder cancer	0.00109	0.00109	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—ERBB3—gallbladder cancer	0.00109	0.00109	CbGpPWpGaD
Loperamide—CALM2—Signaling by PDGF—KRAS—gallbladder cancer	0.00109	0.00109	CbGpPWpGaD
Loperamide—CALM1—Signaling by PDGF—KRAS—gallbladder cancer	0.00109	0.00109	CbGpPWpGaD
Loperamide—CALM2—Downstream signaling of activated FGFR—HRAS—gallbladder cancer	0.00108	0.00108	CbGpPWpGaD
Loperamide—CALM1—Downstream signaling of activated FGFR—HRAS—gallbladder cancer	0.00108	0.00108	CbGpPWpGaD
Loperamide—CALM3—NGF signalling via TRKA from the plasma membrane—EGFR—gallbladder cancer	0.00108	0.00108	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—NRAS—gallbladder cancer	0.00107	0.00107	CbGpPWpGaD
Loperamide—CALM3—B Cell Activation—KRAS—gallbladder cancer	0.00106	0.00106	CbGpPWpGaD
Loperamide—CALM3—Downstream signal transduction—HRAS—gallbladder cancer	0.00105	0.00105	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—ERBB3—gallbladder cancer	0.00105	0.00105	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—ERBB3—gallbladder cancer	0.00105	0.00105	CbGpPWpGaD
Loperamide—CALM3—Signaling by FGFR—HRAS—gallbladder cancer	0.00105	0.00105	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—ERBB3—gallbladder cancer	0.00104	0.00104	CbGpPWpGaD
Loperamide—CALM3—Signaling by ERBB2—HRAS—gallbladder cancer	0.00104	0.00104	CbGpPWpGaD
Loperamide—CALM2—NGF signalling via TRKA from the plasma membrane—EGFR—gallbladder cancer	0.00104	0.00104	CbGpPWpGaD
Loperamide—CALM1—NGF signalling via TRKA from the plasma membrane—EGFR—gallbladder cancer	0.00104	0.00104	CbGpPWpGaD
Loperamide—CALM3—DAP12 signaling—HRAS—gallbladder cancer	0.00104	0.00104	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—ERBB4—gallbladder cancer	0.00103	0.00103	CbGpPWpGaD
Loperamide—CALM2—B Cell Activation—KRAS—gallbladder cancer	0.00103	0.00103	CbGpPWpGaD
Loperamide—CALM1—B Cell Activation—KRAS—gallbladder cancer	0.00103	0.00103	CbGpPWpGaD
Loperamide—CALM1—Downstream signal transduction—HRAS—gallbladder cancer	0.00102	0.00102	CbGpPWpGaD
Loperamide—CALM2—Downstream signal transduction—HRAS—gallbladder cancer	0.00102	0.00102	CbGpPWpGaD
Loperamide—CALM3—NGF signalling via TRKA from the plasma membrane—KRAS—gallbladder cancer	0.00102	0.00102	CbGpPWpGaD
Loperamide—CALM2—Signaling by FGFR—HRAS—gallbladder cancer	0.00101	0.00101	CbGpPWpGaD
Loperamide—CALM1—Signaling by FGFR—HRAS—gallbladder cancer	0.00101	0.00101	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—ERBB3—gallbladder cancer	0.00101	0.00101	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—ERBB3—gallbladder cancer	0.00101	0.00101	CbGpPWpGaD
Loperamide—CALM2—Signaling by ERBB2—HRAS—gallbladder cancer	0.00101	0.00101	CbGpPWpGaD
Loperamide—CALM1—Signaling by ERBB2—HRAS—gallbladder cancer	0.00101	0.00101	CbGpPWpGaD
Loperamide—CALM2—DAP12 signaling—HRAS—gallbladder cancer	0.001	0.001	CbGpPWpGaD
Loperamide—CALM1—DAP12 signaling—HRAS—gallbladder cancer	0.001	0.001	CbGpPWpGaD
Loperamide—CALM2—NGF signalling via TRKA from the plasma membrane—KRAS—gallbladder cancer	0.000983	0.000983	CbGpPWpGaD
Loperamide—CALM1—NGF signalling via TRKA from the plasma membrane—KRAS—gallbladder cancer	0.000983	0.000983	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—EGFR—gallbladder cancer	0.000976	0.000976	CbGpPWpGaD
Loperamide—CALM3—Fc epsilon receptor (FCERI) signaling—HRAS—gallbladder cancer	0.000975	0.000975	CbGpPWpGaD
Loperamide—CALM3—DAP12 interactions—HRAS—gallbladder cancer	0.000975	0.000975	CbGpPWpGaD
Loperamide—CALM3—Signaling by FGFR in disease—HRAS—gallbladder cancer	0.000975	0.000975	CbGpPWpGaD
Loperamide—CALM3—Signaling by EGFR—HRAS—gallbladder cancer	0.000966	0.000966	CbGpPWpGaD
Loperamide—CALM3—Signaling by EGFR in Cancer—HRAS—gallbladder cancer	0.000958	0.000958	CbGpPWpGaD
Loperamide—CALM3—Signaling by PDGF—HRAS—gallbladder cancer	0.000954	0.000954	CbGpPWpGaD
Loperamide—CALM1—Signaling by FGFR in disease—HRAS—gallbladder cancer	0.000943	0.000943	CbGpPWpGaD
Loperamide—CALM2—Fc epsilon receptor (FCERI) signaling—HRAS—gallbladder cancer	0.000943	0.000943	CbGpPWpGaD
Loperamide—CALM2—Signaling by FGFR in disease—HRAS—gallbladder cancer	0.000943	0.000943	CbGpPWpGaD
Loperamide—CALM2—DAP12 interactions—HRAS—gallbladder cancer	0.000943	0.000943	CbGpPWpGaD
Loperamide—CALM1—Fc epsilon receptor (FCERI) signaling—HRAS—gallbladder cancer	0.000943	0.000943	CbGpPWpGaD
Loperamide—CALM1—DAP12 interactions—HRAS—gallbladder cancer	0.000943	0.000943	CbGpPWpGaD
Loperamide—CALM1—Signaling by EGFR—HRAS—gallbladder cancer	0.000935	0.000935	CbGpPWpGaD
Loperamide—CALM2—Signaling by EGFR—HRAS—gallbladder cancer	0.000935	0.000935	CbGpPWpGaD
Loperamide—CALM2—Signaling by EGFR in Cancer—HRAS—gallbladder cancer	0.000927	0.000927	CbGpPWpGaD
Loperamide—CALM1—Signaling by EGFR in Cancer—HRAS—gallbladder cancer	0.000927	0.000927	CbGpPWpGaD
Loperamide—CALM1—Signaling by PDGF—HRAS—gallbladder cancer	0.000923	0.000923	CbGpPWpGaD
Loperamide—CALM2—Signaling by PDGF—HRAS—gallbladder cancer	0.000923	0.000923	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—KRAS—gallbladder cancer	0.000922	0.000922	CbGpPWpGaD
Loperamide—CALM3—Signaling by NGF—NRAS—gallbladder cancer	0.000908	0.000908	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—ERBB4—gallbladder cancer	0.000904	0.000904	CbGpPWpGaD
Loperamide—CALM3—B Cell Activation—HRAS—gallbladder cancer	0.000902	0.000902	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—ERBB3—gallbladder cancer	0.000891	0.000891	CbGpPWpGaD
Loperamide—CALM3—Transmission across Chemical Synapses—HRAS—gallbladder cancer	0.000884	0.000884	CbGpPWpGaD
Loperamide—CALM1—Signaling by NGF—NRAS—gallbladder cancer	0.000878	0.000878	CbGpPWpGaD
Loperamide—CALM2—Signaling by NGF—NRAS—gallbladder cancer	0.000878	0.000878	CbGpPWpGaD
Loperamide—CALM1—B Cell Activation—HRAS—gallbladder cancer	0.000873	0.000873	CbGpPWpGaD
Loperamide—CALM2—B Cell Activation—HRAS—gallbladder cancer	0.000873	0.000873	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—gallbladder cancer	0.000866	0.000866	CbGpPWpGaD
Loperamide—CALM3—NGF signalling via TRKA from the plasma membrane—HRAS—gallbladder cancer	0.000864	0.000864	CbGpPWpGaD
Loperamide—CALM2—Transmission across Chemical Synapses—HRAS—gallbladder cancer	0.000855	0.000855	CbGpPWpGaD
Loperamide—CALM1—Transmission across Chemical Synapses—HRAS—gallbladder cancer	0.000855	0.000855	CbGpPWpGaD
Loperamide—CALM2—NGF signalling via TRKA from the plasma membrane—HRAS—gallbladder cancer	0.000835	0.000835	CbGpPWpGaD
Loperamide—CALM1—NGF signalling via TRKA from the plasma membrane—HRAS—gallbladder cancer	0.000835	0.000835	CbGpPWpGaD
Loperamide—CALM3—Signaling by NGF—EGFR—gallbladder cancer	0.000827	0.000827	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—TP53—gallbladder cancer	0.000819	0.000819	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	0.000818	0.000818	CbGpPWpGaD
Loperamide—CALM2—Signaling by NGF—EGFR—gallbladder cancer	0.0008	0.0008	CbGpPWpGaD
Loperamide—CALM1—Signaling by NGF—EGFR—gallbladder cancer	0.0008	0.0008	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—HRAS—gallbladder cancer	0.000784	0.000784	CbGpPWpGaD
Loperamide—CALM3—Signaling by NGF—KRAS—gallbladder cancer	0.000782	0.000782	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—ERBB3—gallbladder cancer	0.000781	0.000781	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—ERBB4—gallbladder cancer	0.000764	0.000764	CbGpPWpGaD
Loperamide—CALM2—Signaling by NGF—KRAS—gallbladder cancer	0.000756	0.000756	CbGpPWpGaD
Loperamide—CALM1—Signaling by NGF—KRAS—gallbladder cancer	0.000756	0.000756	CbGpPWpGaD
Loperamide—CALM3—Immune System—ERBB4—gallbladder cancer	0.000731	0.000731	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	0.000727	0.000727	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—NRAS—gallbladder cancer	0.00072	0.00072	CbGpPWpGaD
Loperamide—CALM2—Immune System—ERBB4—gallbladder cancer	0.000708	0.000708	CbGpPWpGaD
Loperamide—CALM1—Immune System—ERBB4—gallbladder cancer	0.000708	0.000708	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—BCL2—gallbladder cancer	0.000701	0.000701	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—ERBB2—gallbladder cancer	0.000681	0.000681	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—BCL2—gallbladder cancer	0.000678	0.000678	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—BCL2—gallbladder cancer	0.000678	0.000678	CbGpPWpGaD
Loperamide—CALM3—Neuronal System—HRAS—gallbladder cancer	0.000678	0.000678	CbGpPWpGaD
Loperamide—CALM3—Disease—ERBB4—gallbladder cancer	0.000675	0.000675	CbGpPWpGaD
Loperamide—CALM3—Signaling by NGF—HRAS—gallbladder cancer	0.000664	0.000664	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—ERBB3—gallbladder cancer	0.00066	0.00066	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—ERBB2—gallbladder cancer	0.000659	0.000659	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—ERBB2—gallbladder cancer	0.000659	0.000659	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—EGFR—gallbladder cancer	0.000656	0.000656	CbGpPWpGaD
Loperamide—CALM2—Neuronal System—HRAS—gallbladder cancer	0.000655	0.000655	CbGpPWpGaD
Loperamide—CALM1—Neuronal System—HRAS—gallbladder cancer	0.000655	0.000655	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—ERBB2—gallbladder cancer	0.000654	0.000654	CbGpPWpGaD
Loperamide—CALM2—Disease—ERBB4—gallbladder cancer	0.000653	0.000653	CbGpPWpGaD
Loperamide—CALM1—Disease—ERBB4—gallbladder cancer	0.000653	0.000653	CbGpPWpGaD
Loperamide—CALM2—Signaling by NGF—HRAS—gallbladder cancer	0.000643	0.000643	CbGpPWpGaD
Loperamide—CALM1—Signaling by NGF—HRAS—gallbladder cancer	0.000643	0.000643	CbGpPWpGaD
Loperamide—CALM3—Immune System—ERBB3—gallbladder cancer	0.000632	0.000632	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—ERBB2—gallbladder cancer	0.000632	0.000632	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—ERBB2—gallbladder cancer	0.000632	0.000632	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—NRAS—gallbladder cancer	0.000631	0.000631	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—KRAS—gallbladder cancer	0.000619	0.000619	CbGpPWpGaD
Loperamide—CALM1—Immune System—ERBB3—gallbladder cancer	0.000612	0.000612	CbGpPWpGaD
Loperamide—CALM2—Immune System—ERBB3—gallbladder cancer	0.000612	0.000612	CbGpPWpGaD
Loperamide—CALM3—Disease—ERBB3—gallbladder cancer	0.000584	0.000584	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—NRAS—gallbladder cancer	0.000575	0.000575	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—EGFR—gallbladder cancer	0.000575	0.000575	CbGpPWpGaD
Loperamide—CALM2—Disease—ERBB3—gallbladder cancer	0.000565	0.000565	CbGpPWpGaD
Loperamide—CALM1—Disease—ERBB3—gallbladder cancer	0.000565	0.000565	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—ERBB2—gallbladder cancer	0.000559	0.000559	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—NRAS—gallbladder cancer	0.000556	0.000556	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—NRAS—gallbladder cancer	0.000556	0.000556	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—KRAS—gallbladder cancer	0.000543	0.000543	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—NRAS—gallbladder cancer	0.000533	0.000533	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—HRAS—gallbladder cancer	0.000526	0.000526	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—NRAS—gallbladder cancer	0.000518	0.000518	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—NRAS—gallbladder cancer	0.000501	0.000501	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—NRAS—gallbladder cancer	0.000501	0.000501	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—NRAS—gallbladder cancer	0.000497	0.000497	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—KRAS—gallbladder cancer	0.000495	0.000495	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—ERBB2—gallbladder cancer	0.00049	0.00049	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—EGFR—gallbladder cancer	0.000486	0.000486	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—NRAS—gallbladder cancer	0.000481	0.000481	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—NRAS—gallbladder cancer	0.000481	0.000481	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—KRAS—gallbladder cancer	0.000479	0.000479	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—KRAS—gallbladder cancer	0.000479	0.000479	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—ERBB4—gallbladder cancer	0.000473	0.000473	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—EGFR—gallbladder cancer	0.000472	0.000472	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—HRAS—gallbladder cancer	0.000462	0.000462	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—KRAS—gallbladder cancer	0.000459	0.000459	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—ERBB4—gallbladder cancer	0.000457	0.000457	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—ERBB4—gallbladder cancer	0.000457	0.000457	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—EGFR—gallbladder cancer	0.000456	0.000456	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—EGFR—gallbladder cancer	0.000456	0.000456	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—EGFR—gallbladder cancer	0.000453	0.000453	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—KRAS—gallbladder cancer	0.000446	0.000446	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—TP53—gallbladder cancer	0.00044	0.00044	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—EGFR—gallbladder cancer	0.000438	0.000438	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—EGFR—gallbladder cancer	0.000438	0.000438	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—KRAS—gallbladder cancer	0.000431	0.000431	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—KRAS—gallbladder cancer	0.000431	0.000431	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—KRAS—gallbladder cancer	0.000428	0.000428	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—TP53—gallbladder cancer	0.000426	0.000426	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—TP53—gallbladder cancer	0.000426	0.000426	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—NRAS—gallbladder cancer	0.000425	0.000425	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—HRAS—gallbladder cancer	0.000421	0.000421	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—ERBB2—gallbladder cancer	0.000414	0.000414	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—KRAS—gallbladder cancer	0.000414	0.000414	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—KRAS—gallbladder cancer	0.000414	0.000414	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—ERBB3—gallbladder cancer	0.000409	0.000409	CbGpPWpGaD
Loperamide—CALM3—Immune System—BCL2—gallbladder cancer	0.000408	0.000408	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—HRAS—gallbladder cancer	0.000407	0.000407	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—HRAS—gallbladder cancer	0.000407	0.000407	CbGpPWpGaD
Loperamide—CALM3—Immune System—ERBB2—gallbladder cancer	0.000396	0.000396	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—ERBB3—gallbladder cancer	0.000395	0.000395	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—ERBB3—gallbladder cancer	0.000395	0.000395	CbGpPWpGaD
Loperamide—CALM1—Immune System—BCL2—gallbladder cancer	0.000395	0.000395	CbGpPWpGaD
Loperamide—CALM2—Immune System—BCL2—gallbladder cancer	0.000395	0.000395	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—HRAS—gallbladder cancer	0.00039	0.00039	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—EGFR—gallbladder cancer	0.000387	0.000387	CbGpPWpGaD
Loperamide—CALM2—Immune System—ERBB2—gallbladder cancer	0.000384	0.000384	CbGpPWpGaD
Loperamide—CALM1—Immune System—ERBB2—gallbladder cancer	0.000384	0.000384	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—HRAS—gallbladder cancer	0.000379	0.000379	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—NRAS—gallbladder cancer	0.000373	0.000373	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—HRAS—gallbladder cancer	0.000367	0.000367	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—HRAS—gallbladder cancer	0.000367	0.000367	CbGpPWpGaD
Loperamide—CALM3—Disease—ERBB2—gallbladder cancer	0.000366	0.000366	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—KRAS—gallbladder cancer	0.000366	0.000366	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—HRAS—gallbladder cancer	0.000364	0.000364	CbGpPWpGaD
Loperamide—CALM2—Disease—ERBB2—gallbladder cancer	0.000354	0.000354	CbGpPWpGaD
Loperamide—CALM1—Disease—ERBB2—gallbladder cancer	0.000354	0.000354	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—HRAS—gallbladder cancer	0.000352	0.000352	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—HRAS—gallbladder cancer	0.000352	0.000352	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—EGFR—gallbladder cancer	0.00034	0.00034	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—NRAS—gallbladder cancer	0.00033	0.00033	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—TP53—gallbladder cancer	0.000325	0.000325	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—KRAS—gallbladder cancer	0.000321	0.000321	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—NRAS—gallbladder cancer	0.000319	0.000319	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—NRAS—gallbladder cancer	0.000319	0.000319	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—NRAS—gallbladder cancer	0.000315	0.000315	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—HRAS—gallbladder cancer	0.000311	0.000311	CbGpPWpGaD
Loperamide—CALM3—Immune System—NRAS—gallbladder cancer	0.000302	0.000302	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—EGFR—gallbladder cancer	0.000301	0.000301	CbGpPWpGaD
Loperamide—CALM2—Immune System—NRAS—gallbladder cancer	0.000292	0.000292	CbGpPWpGaD
Loperamide—CALM1—Immune System—NRAS—gallbladder cancer	0.000292	0.000292	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—EGFR—gallbladder cancer	0.000291	0.000291	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—EGFR—gallbladder cancer	0.000291	0.000291	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—EGFR—gallbladder cancer	0.000287	0.000287	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—TP53—gallbladder cancer	0.000285	0.000285	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—KRAS—gallbladder cancer	0.000284	0.000284	CbGpPWpGaD
Loperamide—CALM3—Disease—NRAS—gallbladder cancer	0.000279	0.000279	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—KRAS—gallbladder cancer	0.000275	0.000275	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—KRAS—gallbladder cancer	0.000275	0.000275	CbGpPWpGaD
Loperamide—CALM3—Immune System—EGFR—gallbladder cancer	0.000275	0.000275	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—HRAS—gallbladder cancer	0.000273	0.000273	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—KRAS—gallbladder cancer	0.000271	0.000271	CbGpPWpGaD
Loperamide—CALM2—Disease—NRAS—gallbladder cancer	0.000269	0.000269	CbGpPWpGaD
Loperamide—CALM1—Disease—NRAS—gallbladder cancer	0.000269	0.000269	CbGpPWpGaD
Loperamide—CALM2—Immune System—EGFR—gallbladder cancer	0.000266	0.000266	CbGpPWpGaD
Loperamide—CALM1—Immune System—EGFR—gallbladder cancer	0.000266	0.000266	CbGpPWpGaD
Loperamide—CALM3—Immune System—KRAS—gallbladder cancer	0.00026	0.00026	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—ERBB2—gallbladder cancer	0.000256	0.000256	CbGpPWpGaD
Loperamide—CALM3—Disease—EGFR—gallbladder cancer	0.000254	0.000254	CbGpPWpGaD
Loperamide—CALM2—Immune System—KRAS—gallbladder cancer	0.000251	0.000251	CbGpPWpGaD
Loperamide—CALM1—Immune System—KRAS—gallbladder cancer	0.000251	0.000251	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—ERBB2—gallbladder cancer	0.000248	0.000248	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—ERBB2—gallbladder cancer	0.000248	0.000248	CbGpPWpGaD
Loperamide—CALM2—Disease—EGFR—gallbladder cancer	0.000245	0.000245	CbGpPWpGaD
Loperamide—CALM1—Disease—EGFR—gallbladder cancer	0.000245	0.000245	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—HRAS—gallbladder cancer	0.000242	0.000242	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TP53—gallbladder cancer	0.000241	0.000241	CbGpPWpGaD
Loperamide—CALM3—Disease—KRAS—gallbladder cancer	0.00024	0.00024	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—HRAS—gallbladder cancer	0.000234	0.000234	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—HRAS—gallbladder cancer	0.000234	0.000234	CbGpPWpGaD
Loperamide—CALM2—Disease—KRAS—gallbladder cancer	0.000232	0.000232	CbGpPWpGaD
Loperamide—CALM1—Disease—KRAS—gallbladder cancer	0.000232	0.000232	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—HRAS—gallbladder cancer	0.00023	0.00023	CbGpPWpGaD
Loperamide—CALM3—Immune System—HRAS—gallbladder cancer	0.000221	0.000221	CbGpPWpGaD
Loperamide—CALM1—Immune System—HRAS—gallbladder cancer	0.000213	0.000213	CbGpPWpGaD
Loperamide—CALM2—Immune System—HRAS—gallbladder cancer	0.000213	0.000213	CbGpPWpGaD
Loperamide—CALM3—Disease—HRAS—gallbladder cancer	0.000204	0.000204	CbGpPWpGaD
Loperamide—CALM2—Disease—HRAS—gallbladder cancer	0.000197	0.000197	CbGpPWpGaD
Loperamide—CALM1—Disease—HRAS—gallbladder cancer	0.000197	0.000197	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—NRAS—gallbladder cancer	0.000195	0.000195	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—NRAS—gallbladder cancer	0.000189	0.000189	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—NRAS—gallbladder cancer	0.000189	0.000189	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—EGFR—gallbladder cancer	0.000178	0.000178	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—EGFR—gallbladder cancer	0.000172	0.000172	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—EGFR—gallbladder cancer	0.000172	0.000172	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—KRAS—gallbladder cancer	0.000168	0.000168	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—KRAS—gallbladder cancer	0.000162	0.000162	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—KRAS—gallbladder cancer	0.000162	0.000162	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TP53—gallbladder cancer	0.000149	0.000149	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TP53—gallbladder cancer	0.000144	0.000144	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TP53—gallbladder cancer	0.000144	0.000144	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—HRAS—gallbladder cancer	0.000143	0.000143	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—HRAS—gallbladder cancer	0.000138	0.000138	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—HRAS—gallbladder cancer	0.000138	0.000138	CbGpPWpGaD
